Skip to main content
EyeGene,Inc logo

EyeGene,Inc — Investor Relations & Filings

Ticker · 185490 ISIN · KR7185490000 KO Professional, scientific and technical activities
Open in API
Filings indexed 314 across all filing types
Latest filing 2021-06-15 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 185490

About EyeGene,Inc

https://eyegene.co.kr/en/

EyeGene, Inc. is a clinical-stage biopharmaceutical company that researches and develops innovative therapeutics, with a primary focus on gene and cell therapy for age-related diseases. The company's pipeline includes EG-Mirotin, a treatment candidate for non-proliferative diabetic retinopathy and dry age-related macular degeneration. EyeGene is also developing preventive vaccines, such as EG-HPV for cervical cancer, utilizing its proprietary EG-Vac adjuvant system to enhance vaccine efficacy. The company is dedicated to creating transformative treatments by advancing biomedical science.

Recent filings

Filing Released Lang Actions
[기재정정]주요사항보고서(유무상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) regarding a decision on capital increase (both paid-in and bonus issues) for Eyegene Inc. It details the issuance price, purpose of funds, and allocation methods. This type of regulatory filing in the Korean market (DART system) specifically pertains to capital structure changes and financing activities, which falls under the 'Capital/Financing Update' category.
2021-06-15 Korean
[기재정정]투자설명서
Capital/Financing Update Classification · 98% confidence The document is a 'Correction Report' (정정신고) for an 'Investment Prospectus' (투자설명서) regarding a capital increase (유상증자). It details changes to the final issuance price, total offering amount, and the use of proceeds. In the context of Korean financial filings (DART), this is a formal amendment to a securities registration statement, which falls under the category of regulatory filings related to capital raising.
2021-06-15 Korean
투자판단관련주요경영사항(대상포진 예방백신 ‘EG-HZ’ 호주 1상 임상시험 완료)
Legal Proceedings Report Classification · 95% confidence The document is a formal regulatory filing from the Korean stock exchange (KIND) regarding a 'Major Management Matter' (투자판단 관련 주요경영사항). It details the completion of a Phase 1 clinical trial for a shingles vaccine ('EG-HZ'). Since it is a specific regulatory announcement regarding clinical trial results and business operations, it falls under the 'Regulatory Filings' category as it does not fit into the specific financial report or shareholder meeting categories.
2021-06-14 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership and potential share acquisition rights by major shareholders and special related parties. This type of filing is categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2021-06-11 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard regulatory filing in South Korea (DART system) where company insiders (directors/executives) report their personal share transactions and changes in ownership. This falls under the category of 'Director's Dealing' (DIRS), which covers insider trades and changes in shareholdings by company management.
2021-06-11 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the changes in share ownership (specifically stock warrants) by an executive (Cho Yang-je) of Eyegene Inc. This type of filing is a standard regulatory requirement for insider trading/ownership reporting, which falls under the 'Director's Dealing' category.
2021-06-11 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.